HomeAbout Us Executive Committee

Executive Committee
2015 - 2016

Officers

  • President


    Leonard G. Gomella, MD, FACS
    Show More
    Thomas Jefferson University
    Dept of Urology
    1025 Walnut St.
    Suite 1112
    Philadelphia, PA 19107-5005
    Leonard G. Gomella, MD, FACS

    Dr. Leonard Gomella is the Bernard W. Godwin, Jr. Professor of Prostate Cancer and Chairman of the Department of Urology at the Sidney Kimmel Medical College. In 2015 he became President of the Society of Urologic Oncology. Originally from New York, Dr. Gomella completed medical school, general surgery and urology training at the University of Kentucky in Lexington. After a Urologic Oncology Fellowship in the Surgery Branch of the NCI in Bethesda, Maryland, he joined the Jefferson faculty in 1988 and was appointed Chair in 2002. He serves as Senior Director for Clinical Affairs for the Sidney Kimmel Cancer at Jefferson, Clinical Director of the Sidney Kimmel Cancer Center Network and Urology Chair for RTOG (now NRG).

    Dr. Gomella is involved in translational basic science and clinical research in the development of new diagnostic techniques and treatments for prostate, bladder and kidney cancer through the Sidney Kimmel Cancer Center. Dr. Gomella's team was first to use RT-PCR to detect circulating micrometastasis in patients with prostate cancer, a discovery that led to a new field of investigation in this disease. Dr. Gomella is also recognized as an early contributor to urologic laparoscopy, initiating the program at Jefferson in 1990.

    He has given over 500 presentations nationally and internationally and written over 400 papers, chapters and monographs in the field of Urology. He is a consultant to over 2 dozen journals in the field of urology and oncology and in 2010 became Editor-in-Chief of the “Canadian Journal of Urology”.

    Dr. Gomella has authored and edited 63 editions of 17 different books for medical students, residents, and practicing physicians, many of which have been translated into foreign languages. He is the Editor-in-Chief of the “5 Minute Urology Consult” now in its 3rd edition, laparoscopy editor for 2 editions of “Glenn’s Urologic Surgery” and co-author of the "Oxford American Handbook of Urology". "Recovering from Prostate Cancer”, the first book for the public dedicated to prostate cancer, was authored by Dr. Gomella in 1993. In the field of medicine, he is well known for the "Clinician's Pocket Reference", now in its 11th edition, and the annual "Clinician's Pocket Drug Reference" both widely used medical references.

    “Best Doctors in America”, “Top Doctors for Cancer”, Philadelphia Magazine’s “Top Doctors” have recognized him for many years for urologic oncology and prostate cancer including a 2015 national recognition in Newsweek. In 2007, Men’s Health Magazine listed Dr. Gomella as one of the 20 top urologists in the US. Awards have included the American Cancer Society "Volunteer Achievement Award" and an “NCI Achievement Award”. He has been President of the Mid-Atlantic Section of the AUA and elected to the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons. The University of Kentucky College of Medicine awarded him an "Distinguished Alumnus Award” in 2009. In 2015 he received a “Distinguished Contribution Award” from the AUA and from Thomas Jefferson University and Hospital the “Jefferson Achievement Award in Medicine”.
  • President-Elect


    Christopher Paul Evans, MD, FACS
    Show More
    UC Davis
    Department of Urology
    4860 Y Street
    Suite 3500
    Sacramento, CA 95817
    Christopher P. Evans, MD, FACS

    Dr. Evans is professor and chairman of the Department of Urology at University of California, Davis School of Medicine and a member of the UC Davis Cancer Center. Dr. Evans attended Dartmouth Medical School on a Health Professional Services Program scholarship and he served on active duty in the United States Army, including two years as Chief of Experimental Surgery at the Walter Reed Army Institute of Research. He completed surgery and urology training at the University of California, San Francisco where he was also a National Kidney Foundation Scholar. Dr. Evans completed fellowship training in urologic oncology at the University of Texas, MD Anderson Cancer Center. He came to UC Davis in 1997 at which time he was also Director of Urology Research. In 2006, Dr. Evans became Department Chairman, and in 2010 he became Chairman of the UC Davis Medical Group Practice Management Board. Dr. Evans’ practice is dedicated to the management of patients with urologic malignancies. He works with medical oncologists and radiation oncologists to provide multimodal approaches to cancer therapy.

    Dr. Evans’ research laboratory focuses on prostate cancer; specifically, mechanisms signaling the androgen receptor to activate prostate cancer growth and progression following castration. His laboratory has developed models to study this and has identified novel mechanisms that activate the androgen receptor. His laboratory work has tested new agents and brought them from bench studies to animal models to clinical trials.

    Dr. Evans is president-elect of the Society of Urologic Oncology and is Chair of the ASCO-GU Steering Committee. He is also an elected member of the American Association of Genitourinary Surgeons. His research laboratory has received funding from the National Institute of Health, Department Of Defense, New York Academy of Medicine, Prostate Cancer Foundation, and the American Cancer Society. He has published over 125 peer-reviewed articles.
  • Secretary


    Jeffrey Maxwell Holzbeierlein, MD, FACS
    Show More
    University of Kansas Medical Center
    3901 Rainbow Blvd.
    MS-3016
    Kansas City, KS 66160
    Jeffrey Holzbeierlein, MD

    Dr. Jeffrey Holzbeierlein is the John W. Weigel Endowed Professor of Urology and the Director of Urologic Oncology at the University of Kansas Medical Center. He was raised in Edmond, Oklahoma and received his undergraduate degree from Vanderbilt University where he played for the men’s tennis team. He received his medical degree from the University of Oklahoma and joined the faculty at KU after completing his internship and residency at Vanderbilt University and a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York.

    Dr. Holzbeierlein is a member of the Society of Urologic Oncology where he is the past Chair of the Fellowship Committee and serves on the Executive Board of the SUO. He is the President-Elect of the South Central Section of the American Urological Association and serves on the Board of Directors. He has served on the American Board of Urology Examination Committee and is currently and Oral Examiner for the Board Exams. He is a past Assistant Editor for the Journal of Urology. Dr. Holzbeierein has served on numerous AUA Committees including: the Practice Guidelines Committee and the Public Media Committee and has completed the AUA Leadership Program. In addition, he is a Fellow of the American College of Surgeons and serves on the Kansas selection board. Dr. Holzbeierlein is also the past Chair and founding member of the Young Urologic Oncologists Section of the Society of Urologic Oncology. He is a reviewer for the Journal of Urology, Practical Reviews in Urology, Cancer, and Urologic Oncology. He was recently awarded the Resident Mentoring Award for faculty at the University of Kansas Hospital.

    Dr. Holzbeierlein serves on numerous hospital committees including the University of Kansas Physicians Board of Directors, the Promotions and Tenure Committee, the Elections Committee for the School of Medicine, and the Board for the Kansas Tissue and Serum Repository. He is also co-director of the K-Inbre Translational Research Core, and the Director of the Genitourinary Disease Working Group. He is the Director of the Burns and McDonnell High Risk Prostate Cancer Prevention and Survivorship Clinic at the University of Kansas Cancer Center.

    Dr. Holzbeierlein has published numerous peer reviewed journal articles, and has numerous presentation and abstracts in journals and textbooks dealing with urologic oncology. He has been an annual lecturer for an AUA Course focusing on the Management of High Risk Superficial Bladder Cancer which was selected as one of the “best courses” at the AUA. He has intramural and extramural grant support including a co-investigator on an R01, and as PI on several investigator initiated trials and Pharma trials.

    Dr. Holzbeierlein specializes in the treatment of genitourinary malignancies including prostate, bladder, kidney, testicular, and penile cancers. His research interest includes the androgen receptor as a target of Hsp90 inhibitors in prostate cancer and clinically decreasing the morbidity associated with cystectomy. He lives in Kansas City with his wife Jill and their 4 children, and is civically active at the Hope Lodge of Kansas City and Maisson deNaissance.
  • Treasurer


    Michael S. Cookson, MD, MMHC
    Show More
    University of Oklahoma
    Health Sciences Center
    920 Stanton L. Young Blvd.
    WP3150
    Oklahoma City, OK 73104
    Michael S. Cookson, MD

    Michael S. Cookson, MD is Professor and Chairman of the Department of Urology at the University of Oklahoma Health Sciences Center, and holds the Donald D. Albers Endowed Chair in Urology. An accomplished researcher and lecturer, he is the author of 206 peer-reviewed journal publications and 28 chapters of various textbooks in urology and urologic surgery, and has been recognized nationally for his outstanding contributions to urologic oncology.

    Dr. Cookson completed his Urology residency at the University of Texas, San Antonio and completed his Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. He was a member of the faculty at Vanderbilt University from 1998 to 2013, where he served as the Vice Chairman of Urologic Surgery and Director of the Urologic Oncology Fellowship Program.

    Dr. Cookson has devoted a significant portion of his academic career to the management of patients with urologic cancers, with a strong emphasis on Clinical Guidelines, Education and Evidenced Based Medicine. He was a member of the AUA/ABU examination committee for 10 years, including a member of Task for Cancer, Oncology Consultant and Pathology editor. He also serves on the ABU Oral Examination Committee. He is a co-founder of the OKAT, an SUO mandated oncology examination that is the standard for benchmarking for members and oncology fellows in training and served as Chair of that OKAT committee for 5 years. In 2011, he received the President’s Distinguished Service Award from the SUO for educational contributions. For his efforts in teaching at Vanderbilt, he was awarded the Michael Rodriquez Award.

    Dr. Cookson recently served as the Chair of the AUA Guidelines Committee on Castration Resistant Prostate Cancer, and has previously served as the member of the AUA Guidelines on localized prostate cancer. He currently serves as Treasurer for the Society of Urologic Oncology.
  • Past President


    James Brantley Thrasher, MD, FACS
    Show More
    University of Kansas Medical Center
    Department of Urology
    3901 Rainbow Blvd. MS 3016
    Kansas City, KS 66160
    J. Brantley Thrasher, MD, FACS

    Dr. J. Brantley Thrasher is Professor and the William L. Valk Chair, Department of Urology and the Co-Director of Operative Services at the University of Kansas Medical Center in Kansas City, Kansas. A native of South Carolina, he completed his Medical Degree at the Medical University of South Carolina in Charleston, South Carolina, an internship at Walter Reed Army Medical Center in Washington D.C., and his urology residency at Fitzsimons Army Medical Center in Aurora, Colorado. He subsequently completed a urologic oncology fellowship at Duke University Medical Center. He served for three years as Program Director for the Urology Residency Program at Madigan Army Medical Center in Tacoma, Washington, and after completing his military obligation, he was appointed to his present position in 1998.

    He is the Vice-President of the American Board of Urology, President of the Society of Urology Chairpersons and Program Directors, immediate Past-President of the Society of Urologic Oncology, and a member of the Residency Review Committee for Urology. He served as the South Central Section Representative to the AUA Board of Directors, and will become President-elect of the AUA in 2016. He is a Diplomat of the American Board of Urology, a Fellow of the American College of Surgeons, and a member of the American Association of Genitourinary Surgeons. This year, he was awarded the Distinguished Service Award from the AUA, for 15 years of service to academic and organized urology.

    Dr. Thrasher has served on numerous national committees, including the American Joint Committee on Cancer (AJCC), as the Kansas State Representative to the Board of Directors of the South Central Section of the American Urological Association (AUA), as the Chair of the Fellowship Committee for the Society of Urologic Oncology, and as a member of the American College of Radiology Expert Advisory Panel on Prostate Cancer. He has served as Chairman of the Metropolitan Kansas City Committee on fellowship applicants for the American College of Surgeons, the Past-President of the South Central Section of the AUA, Chair of the Public Media, Practice Guidelines and Prostate Cancer Guidelines (vice-chair) Committees, former member of the AUA Board of Directors; as a mentor for the AUA Leadership Program, a member of the Best Practice Policy Panel on Cryotherapy for the Treatment of Prostate Cancer, the Chair of the Prostate Cancer Literature Review Panel and the Audio-Visual Committee of the AUA.

    In addition to giving over 400 presentations at local, national, and international meetings, he has written over 190 manuscripts, book chapters, and monographs in the field of urology. He currently serves as Coordinating Editor for Practical Reviews in Urology, member of the Editorial Advisory Board of the Journal of American Family Physician, an Associate Editor for the book, “The 5-Minute Urology Consult;” and as an Editorial Consultant for Urology Times.

    Dr. Thrasher’s basic science research interests in the area of prostate cancer and he is currently a co-investigator or consultant in NIH, Center for Disease Control, and Department of Defense funded research. His clinical research interests are in the area of prostate, bladder, and renal cancer, as well as reconstruction, and he serves as the principal investigator on numerous investigator initiated, industry funded, and institutionally funded protocols.

  • Member At Large


    David F. Jarrard, MD
    Show More
    University of Wisconsin
    1685 Highland Ave
    Madison, WI 53705
    David Frazier Jarrard, MD

    David Frazier Jarrard, MD, is a tenured Professor of Surgery and Molecular and Environmental Toxicology at the University of Wisconsin. He obtained his BA and MD from the University of Virginia. He was a junior resident in Surgery, and resident in Urology at the University of Chicago Hospitals. He was a fellow in Urologic Oncology in the Brady Urologic Institute of the Johns Hopkins Hospital. He is currently Vice Chair for the Department of Urology, Chair of the Chemoprevention Program for the UW Carbone Cancer Center, leads the Section of Urologic Oncology and holds the John Livesey Chair in Urologic Oncology. Dr. Jarrard is a member of the American Urological Association (Education, Research Committees), the Eastern Cooperative Oncology Group, the Society for Basic Urologic Research (Past President), and the Society for Urologic Oncology (Board of Directors).

    He has active basic science and translational research interests supported through the National Institutes of Health and the Department of Defense Prostate Cancer Research Programs examining the role of epigenetics and prostate cancer susceptibility with aging. A second area of research focuses on whether cellular senescence can be reinvoked in cancer cells as therapy. His clinical work focuses on Urologic Oncology and improving cancer detection and outcomes. Dr. Jarrard has received the Society for Basic Urologic Research Young Investigator and Distinguished Service Awards, Madison Magazine’s ‘Best Physicians in Wisconsin’, a Castle Connolly ‘Top Doctor’ and is currently a ‘Best Doctor in America’. Dr. Jarrard has published numerous chapters, articles and abstracts in the field of urologic oncology.
  • Member At Large


    Wade Jeffers Sexton, MD
    Show More
    Moffitt Cancer Center
    12902 Magnolia Dr.
    Tampa, FL 33612
    Wade J. Sexton, MD

    Dr. Sexton attended Furman University in Greenville, South Carolina as a scholar-athlete and graduated with a Bachelor of Science Degree in Biology. While at Furman, he started in the defensive backfield for Furman’s National Championship football team. He attended Emory University’s School of Medicine on an Air Force sponsored Health Professions Scholarship and then completed his general surgery and urology residency training at the Wake Forest University Baptist Medical Center. Following the completion of his residency, Dr. Sexton entered active duty military service with the United States Air Force and while on active duty, was selected to perform a Fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center. From 2001-2004, he served as Director of Urologic Oncology with the 59th Medical Wing at Wilford Hall USAF Medical Center in San Antonio, Texas. Thereafter, he joined the Moffitt Cancer Center in Tampa, Florida, where he is now a Senior Member in the Department of Genitourinary Oncology and a Professor in the Department of Oncologic Sciences with the University of South Florida. Since 2008, he has served as Director of the Society of Urologic Oncology accredited Fellowship at the Moffitt Cancer Center.

    Dr. Sexton has held several leadership positions at Moffitt including an extended service on the Medical Executive Committee culminating as President of the Medical Staff from 2014-2016. He is a 2014 graduate of the inaugural Moffitt Cancer Center Leadership Academy. He has served in different capacities with the Florida Urologic Society including president of the FUS from 2015-2016. He is a long-term member of the NCCN guidelines panel for bladder and penile cancers, a faculty member for the AUA’s Annual Board Review Course (testicular cancer) and a member of the Fellowship Committee for the Society of Urologic Oncology. He is primary investigator and collaborator on numerous clinical trials and grant funded translational studies, has authored over 100 manuscripts and book chapters, and maintains an extremely busy clinical practice focused towards bladder, kidney and testicular malignancies. He was awarded a Meritorious Service Medal while on active duty with the United States Air Force. In 2013, it was a tremendous honor for him to be recognized as an MD Anderson Cancer Center Distinguished Alumnus. He has been recognized as a Top Doctor in Tampa Bay and repeatedly as one of America’s Top Physicians, Top Surgeons and Top Doctors for Cancer.
  • Member At Large


    Edouard John Trabulsi, MD, FACS
    Show More
    Thomas Jefferson University
    Kimmel Cancer Center
    Department of Urology
    1025 Walnut Street, Suite 1100
    Philadelphia, PA 19107
    Edouard John Trabulsi, MD, FACS

    Dr. Edouard Trabulsi is an Associate Professor and Vice Chair of Regional Outreach in the Department of Urology at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. He received his Bachelor of Science in Biochemistry cum laude with Distinction in Research from the University of Rochester and completed his medical degree magna cum laude at the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed surgery internship, surgery residency, and urology residency at Thomas Jefferson University. He also completed fellowships in urologic oncology and minimally invasive urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York. He also completed the Vail ASCO/AACR Methods in Clinical Cancer Research Seminar. He is also a member of Alpha Omega Alpha Medical Honor Society.

    Dr. Trabulsi is Director of the Division of Urologic Oncology in the Department of Urology of Thomas Jefferson University, and Co-Director of the Jefferson Prostate Diagnostic Center at Thomas Jefferson University. He is the Director of Clinical Trials in the Department of Urology and Co-Director of the Genitourinary Oncology Multidisciplinary Cancer Center at the Kimmel Cancer of Thomas Jefferson University. He serves as Cancer Liaison to the American College of Surgeons Commission on Cancer for Thomas Jefferson University Hospital. Regionally, he is section secretary and president-elect of the Mid-Atlantic Section of the American Urological Association; and is President of the Philadelphia Urologic Society.

    Dr. Trabulsi serves on numerous national committees, including the American Urologic Association (AUA) Education Council, the AUA Legislative Affairs Committee, the AUA Urologic Diagnostic and Therapeutic Imaging Committee, and the AUA Bylaws committee. He is a graduate of the AUA Leadership Program. He also serves on the executive committee of the AUA Resident Core Curriculum. Within the ECOG-ACRIN cooperative group, Dr. Trabulsi is co-chair of the Early Modality subcommittee of the GU Core Committee. He was elected to the executive board of the Society of Urologic Oncology. He is a member of the American Urologic Association, the American Society of Clinical Oncology, the American Association of Cancer Research, the Society of Urologic Oncology and the American College of Surgeons.

    Dr. Trabulsi has published numerous manuscripts and book chapters in the field of urologic oncology and prostate cancer imaging. His clinical interests include all areas of urologic oncology and minimally invasive surgery, including prostate cancer, bladder cancer, kidney cancer, testis cancer and penile cancer, as well as robotic and laparoscopic surgery. His research interests include contrast-enhanced transrectal ultrasonography, PET imaging of prostate and bladder cancer, outcomes after robotic prostatectomy, and postoperative radiotherapy after radical prostatectomy. He has been designated as one of America’s “Top Doctors” and “Top Doctors for Cancer” several years running, and has been named as a “Top Doc” by Philadelphia magazine.
  • Winter Scientific Program Co-Chairs


    Gerald L. Andriole, Jr., MD
    Show More
    Washington University School of Medicine
    4960 Children's Place, Box 8242
    St. Louis, MO 63110-3055
  • Winter Scientific Program Co-Chairs


    Brett S. Carver, MD
    Show More
    Memorial Sloan Kettering Cancer Center
    1275 York Avenue
    New York, NY 10021
    Dr Brett S. Carver

    Dr Brett S. Carver is an Associate Member of the Department of Surgery Division of Urology at Memorial Sloan Kettering Cancer Center. Dr Carver’s clinical practice focuses on the surgical management of prostate and testicular cancer. As a surgeon-scientist, Dr Carver’s research studies the role of androgen receptor and kinase signaling in the biology and therapeutic management of prostate cancer. Dr Carver is a NIH/NCI funded investigator and director of the Urology T-32 training grant at MSKCC.
  • Young Urologic Oncologists Representative


    Todd Matthew Morgan, MD
    Show More

    1500 E Medical Center Drive
    Ann Arbor, MI 48109
    Todd M. Morgan, M.D.
    Dr. Morgan is a urological surgeon specializing in the treatment of genitourinary malignancies. Previously at Vanderbilt University, he joined the faculty at the University of Michigan in 2012. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology and subsequent faculty appointment at Vanderbilt. Dr. Morgan's research focuses on understanding the early spread of prostate cancer cells, with the aim of identifying those patients with the most aggressive tumors and developing appropriate therapeutic strategies for these individuals.
  • Incoming Spring Scientific Program Co-Chairs


    Scott E. Eggener, MD
    Show More
    University of Chicago Medical Center
    5841 South Maryland Ave, MC-6038
    Chicago, IL 60637
    Scott E. Eggener, MD

    Scott Eggener, MD, is an Associate Professor of Surgery at the University of Chicago and a high-volume robotic and open surgeon who specializes in the care of patients with prostate, kidney and testicular cancer. Dr. Eggener's research -- which has resulted in over 175 publications -- has been presented at national and international meetings. He is a senior faculty scholar at the Bucksbaum Institute for Clinical Excellence, recipient of the SUO Young Investigator Award, and frequently participates in volunteer educational and surgical missions to developing countries.
  • Incoming Spring Scientific Program Co-Chairs


    James Michael McKiernan, MD
    Show More
    Columbia University
    161 Fort Washington Ave., Suite #1153
    New York, NY 10032
    James M. McKiernan, MD

    Dr. James McKiernan graduated from Johns Hopkins University and received his medical degree from Columbia University College of Physicians and Surgeons in 1993. He has remained affiliated with New York-Presbyterian/Columbia University Medical Center for the past 22 years, completing his training in urology and general surgery at the medical center in 1999. Dr. McKiernan then completed a two-year urologic surgical oncology fellowship studying at Memorial Sloan-Kettering Cancer Center. In 2001, Dr. McKiernan was appointed as assistant professor of urology at Columbia University College of Physicians & Surgeons. Dr. McKiernan was named the John and Irene Given Endowed Chair in Urology, and in 2007 was named associate professor of clinical urology. In 2010, Dr McKiernan was promoted to professor of clinical urology and has served as the vice chairman of urology and director of urologic oncology since 2006.

    Dr. McKiernan's practice is limited exclusively to urologic oncology including surgical therapy of bladder, kidney, prostate and testicular cancer. He has a specific interest in treating patients diagnosed with recurrent or high risk cancer diagnoses. In the management of kidney and bladder cancer, Dr. McKiernan has developed specific expertise in organ preservation and reconstructive surgery to maximize quality of life.

    Dr. McKiernan is actively involved in research and discovery with ongoing programs focused on improving patient clinical outcomes with kidney, prostate and bladder cancer and has been published in Urology, Journal of Urology, Journal of Clinical Oncology and Urologic Oncology among others. He has authored and co-authored more than 130 scientific articles and book chapters in the field of urologic oncology. For the past 10 years, he has directed the research efforts at Columbia University in quality outcomes and effectiveness research in urologic cancer surgery. Dr. McKiernan also directs the experimental clinical trials program in intravesical therapy for bladder cancer. This program has helped develop promising new agents for bladder preservation in patients whose cancer has recurred after the use of BCG therapy. In collaboration with the research scientists in the Herbert Irving Comprehensive Cancer Center, this team develops therapeutic strategies for managing bladder cancer.

    Dr. McKiernan is currently the director of urologic medical student education in the Columbia University College of Physicians and Surgeons and is the John and Irene Given Professor of Urology at Columbia University. He is the director of the third and fourth year medical student course in urology and lectures annually to the first and second year medical student class. Since 2002, he has served as the mentor and director of the medical student Doris Duke Charitable Foundation Clinical Scholars Research Fellowship in Urology. Through this position, Dr McKiernan has had the honor of mentoring 16 research fellows over the past 10 years who have gone on to become future leaders in the field of urology. Dr. McKiernan is also the Dean's advisor for career counseling in urology for students in the College of Physician's and Surgeon's and serves on the curriculum development committee for the college. In 2004, Dr McKiernan was voted Teacher of the Year by the residents of the urology department.

  • Spring Scientific Program Co-Chairs


    Stephen Anthony Boorjian, MD
    Show More
    Mayo Clinic
    200 1st St. SW
    Rochester, MN 55905
    Stephen Anthony Boorjian, MD

    Dr. Stephen A. Boorjian is a Professor of Urology, Vice Chair of Research for the Department of Urology, and the Director of the Urologic Oncology Fellowship at Mayo Clinic. He received his MD from Harvard Medical School, and was a resident in Urology at New York Presbyterian Hospital-Weill Cornell Medical Center. He subsequently completed a fellowship in Urologic Oncology at Mayo Clinic. His research interests include optimizing the management for patients with high-risk prostate cancer, evaluating the outcomes among patients undergoing radical cystectomy for bladder cancer, and improving surgical therapy for advanced renal cell carcinoma. Dr. Boorjian has co-authored over 200 manuscripts and book chapters, and was recognized as “Teacher of the Year” in Urology for 2012 by the Mayo Clinic Fellows’ Association. He is a member of the NCCN Guidelines Panels for Bladder Cancer and Penile Cancer, and serves an Associate Editor for European Urology.
  • Spring Scientific Program Co-Chairs


    Alexandre Zlotta, MD
    Show More
    Mount Sinai Hospital
    60 Murray St, 6th Floor, Rm 6004, Box 19
    Toronto, ON M5T 3L9
    CANADA
    Alexandre Zlotta, MD

    Dr. Alexandre Zlotta received his MD from the Free University of Brussels in 1989 and completed his Urology specialization as well as his PhD in Immunology in the same University. He worked as a Uro-Oncologist in the Department of Urology, Erasme Hospital, University Clinics of Brussels until 2006. In 2006, Dr. Zlotta was recruited to Toronto where he was appointed, and is currently, Professor in the Department of Surgery (Urology), University of Toronto, Director of Uro-Oncology, Mount Sinai Hospital, and surgeon at Princess Margaret Cancer Centre, University Health Network. He is also the Director of the Uro-Oncology Fellowship Program, University of Toronto and Director of the Bladder Cancer Research Program. Dr. Zlotta has served as Associate Editor to European Urology and is currently Consulting Editor for European Urology. He is also on several international editorial boards. In addition to being a surgeon, Dr. Zlotta is a translational research scientist with an extended research career that boasts success in both translational research and multi-institutional, international studies. He has a special interest in bladder and prostate cancer research where he has authored over 200 scientific papers. Dr. Zlotta is recognized with numerous awards, the most prestigious being the EAU Matula Award in 2000 and the EAU Platinum award in 2012.
  • AUA Representative


    James Brantley Thrasher, MD, FACS
    Show More
    University of Kansas Medical Center
    Department of Urology
    3901 Rainbow Blvd. MS 3016
    Kansas City, KS 66160
    J. Brantley Thrasher, MD, FACS

    Dr. J. Brantley Thrasher is Professor and the William L. Valk Chair, Department of Urology and the Co-Director of Operative Services at the University of Kansas Medical Center in Kansas City, Kansas. A native of South Carolina, he completed his Medical Degree at the Medical University of South Carolina in Charleston, South Carolina, an internship at Walter Reed Army Medical Center in Washington D.C., and his urology residency at Fitzsimons Army Medical Center in Aurora, Colorado. He subsequently completed a urologic oncology fellowship at Duke University Medical Center. He served for three years as Program Director for the Urology Residency Program at Madigan Army Medical Center in Tacoma, Washington, and after completing his military obligation, he was appointed to his present position in 1998.

    He is the Vice-President of the American Board of Urology, President of the Society of Urology Chairpersons and Program Directors, immediate Past-President of the Society of Urologic Oncology, and a member of the Residency Review Committee for Urology. He served as the South Central Section Representative to the AUA Board of Directors, and will become President-elect of the AUA in 2016. He is a Diplomat of the American Board of Urology, a Fellow of the American College of Surgeons, and a member of the American Association of Genitourinary Surgeons. This year, he was awarded the Distinguished Service Award from the AUA, for 15 years of service to academic and organized urology.

    Dr. Thrasher has served on numerous national committees, including the American Joint Committee on Cancer (AJCC), as the Kansas State Representative to the Board of Directors of the South Central Section of the American Urological Association (AUA), as the Chair of the Fellowship Committee for the Society of Urologic Oncology, and as a member of the American College of Radiology Expert Advisory Panel on Prostate Cancer. He has served as Chairman of the Metropolitan Kansas City Committee on fellowship applicants for the American College of Surgeons, the Past-President of the South Central Section of the AUA, Chair of the Public Media, Practice Guidelines and Prostate Cancer Guidelines (vice-chair) Committees, former member of the AUA Board of Directors; as a mentor for the AUA Leadership Program, a member of the Best Practice Policy Panel on Cryotherapy for the Treatment of Prostate Cancer, the Chair of the Prostate Cancer Literature Review Panel and the Audio-Visual Committee of the AUA.

    In addition to giving over 400 presentations at local, national, and international meetings, he has written over 190 manuscripts, book chapters, and monographs in the field of urology. He currently serves as Coordinating Editor for Practical Reviews in Urology, member of the Editorial Advisory Board of the Journal of American Family Physician, an Associate Editor for the book, “The 5-Minute Urology Consult;” and as an Editorial Consultant for Urology Times.

    Dr. Thrasher’s basic science research interests in the area of prostate cancer and he is currently a co-investigator or consultant in NIH, Center for Disease Control, and Department of Defense funded research. His clinical research interests are in the area of prostate, bladder, and renal cancer, as well as reconstruction, and he serves as the principal investigator on numerous investigator initiated, industry funded, and institutionally funded protocols.

Standing Committee Chairs

  • AJCC Representative